Amphotericin B

AmBisome

Lipid-based Polyene Antifungal

NADAC/unit N/A

No Shortage Tier 1: 39.2% PA Req: 200.0% 5 Manufacturers 5 ANDAs

Covered Lives

Active Shortages

2025-08-08 Discontinuation of the manufacture of the drug, Leadiant Biosciences, Inc.

Market Intelligence

2024-05-15 Class II Recall: SUN PHARMACEUTICAL INDUSTRIES INC

Generic Manufacturers

ASTELLAS PHARMA US INCAVET LIFESCIENCES PRIVATE LTDEUGIA PHARMA SPECIALITIES LTDMYLAN LABORATORIES LTDSUN PHARMA INDUSTRIES LTDXGEN PHARMACEUTICALS DJB INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Amphotericin B drfinder.aiFind doctors who prescribe Amphotericin B rxnews.aiLatest news about Amphotericin B

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.